معرفی
Tom Blundell is a distinguished academic and researcher in structural biology and bioinformatics at the University of Cambridge. He holds the title of Sir William Dunn Professor of Biochemistry and has served in leadership roles including Director of Research in the Department of Biochemistry, Head of the School of Biological Sciences, and Chief Executive of the Biotechnology and Biological Sciences Research Council (BBSRC). His career spans over five decades, with notable contributions to drug design, structural biology, and bioinformatics software development.
Education:
- 1961: Open Scholarship in Natural Sciences, Brasenose College, Oxford University
- 1964: First Class Honours, Brasenose College, Oxford University
- 1967: D.Phil., Oxford University
Research Interests:
- Architecture of macromolecules and their biological functions
- Rational drug design and high-throughput drug discovery
- Development of bioinformatics tools used globally
- Structural basis of diseases like cancer
Awards and Honors:
- Fellow of the Royal Society (1984)
- Knighthood (1997)
- Over 20 major national and international awards
Grants and Industry:
- Secured over £5 million in grants from Wellcome Trust, Gates Foundation, BBSRC, and industry partnerships
- Co-founded Astex Technology Ltd., a leader in structure-based drug design
Labs and Teams: Leads a research group of 25+ postdocs, students, and technical staff. Pioneered methods in structure-based drug design and high-throughput approaches.
